Clinical trial / 2014
Folic acid supplementation did not reduce mood disorder incidence in youth at risk.
A randomized, double-blind, placebo-controlled trial tested daily folic acid (2.5 mg) against placebo for up to 36 months in 112 youth aged 14 to 24 years at familial risk for mood disorders. Mood disorder incidence occurred in 14.3% of the folic acid group and 17.9% of the placebo group, demonstrating no statistically significant difference between treatments. Folic acid was well tolerated, though trial power was limited by sample size and lower-than-anticipated incidence rates.
- Study type
- Randomized controlled trial
- Who was studied
- 112 youth aged 14-24 years at familial risk for mood disorder
- What was measured
- Onset of DSM-IV mood disorder
THE PAPER
Folic acid supplementation for prevention of mood disorders in young people at familial risk: a randomised, double blind, placebo controlled trial.
Sharpley AL, Hockney R, McPeake L, Geddes JR, Cowen PJ. J Affect Disord, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.